Items where authors include "Fox, S"

Article

Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736

Ahearn, TU, Zhang, H, Michailidou, K et al. (202 more authors) (2022) Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Research, 24 (1). 2.

Park, HA, Neumeyer, S, Michailidou, K et al. (274 more authors) (2021) Mendelian randomisation study of smoking exposure in relation to breast cancer risk. British Journal of Cancer, 125. pp. 1135-1145. ISSN 0007-0920

Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736

Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736

Kramer, I, Hooning, MJ, Mavaddat, N et al. (264 more authors) (2020) Breast cancer polygenic risk score and contralateral breast cancer risk. The American Journal of Human Genetics, 107 (5). pp. 837-848. ISSN 0002-9297

Fox, TA, Horne, GA, Craddock, C et al. (6 more authors) (2019) Trial re-investment to build better research for better impact. The Lancet, 394 (10199). pp. 635-636. ISSN 0140-6736

Appleby, N, Eyre, TA, Cabes, M et al. (7 more authors) (2019) The STELLAR trial protocol: a prospective multicentre trial for Richter’s syndrome consisting of a randomised trial investigation CHOP-R with or without acalabrutinib for newly diagnosed RS and a single-arm platform study for evaluation of novel agents in relapsed disease. BMC Cancer, 19 (1). 471. ISSN 1471-2407

Fotios, S, Cheal, C, Fox, S et al. (1 more author) (2019) The transition between lit and unlit sections of road and detection of driving hazards after dark. Lighting Research and Technology, 51 (2). pp. 243-261. ISSN 1477-1535

Fotios, S, Cheal, C, Fox, S et al. (1 more author) (2018) The effect of fog on detection of driving hazards after dark. Lighting Research and Technology, 50 (7). pp. 1024-1044. ISSN 1477-1535

Hall, G, Cullen, E, Sawmynaden, K et al. (11 more authors) (2016) Structure of a potential therapeutic antibody bound to Interleukin-16 (IL-16): mechanistic insights and new therapeutic opportunities. Journal of Biological Chemistry, 291 (32). pp. 16840-16848. ISSN 0021-9258

Conference or Workshop Item

Baird, R, Oliveira, M, Ciruelos Gil, EM et al. (33 more authors) (2021) Abstract PS11-05: Updated data from SERENA-1: A Phase 1 dose escalation and expansion study of the next generation oral SERD AZD9833 as a monotherapy and in combination with palbociclib, in women with ER-positive, HER2-negative advanced breast cancer. In: 2020 San Antonio Breast Cancer Virtual Symposium, 08-11 Dec 2020, San Antonio, Texas, USA.